Maine: 17 New Adult Use Conditional Licenses Issued

MAINE: How big is Maine’s new adult-use cannabis industry? According to the Maine Office of Marijuana Policy, there are 17 new adult use conditional licenses. The breakdown includes seven marijuana stores, five cultivation facilities, four products manufacturing facilities, and one testing facility.

CANADA: Cannalogue Introduces COVID-19 Compassionate Care Program For Medical Cannabis

Physician-led online marketplace offers discount of 20-50% on select products for frontline workers, seniors and financially strained

CANADA: In response to the closure of storefront retailers due to COVID-19, online marketplace Cannalogue announced today a new Compassionate Care Program that seeks to provide better access to medical cannabis for all Canadians. 

Qualified candidates including first responders, seniors, nurses, teachers, and those facing financial strain due to work shortage/layoffs can enroll in the program to receive selected products at a discount of 20-50%.  The doctor-recommended, Health Canada approved products include oils, capsules, and dried flowers from as low as $3.50/gram.  As the most inclusive program in Canada, Cannalogue’s Compassionate Care Program is also available to veterans, individuals currently enrolled in a disability, federal or provincial assistance program and Indigenous peoples.

“COVID-19 has had a devastating effect on all Canadians” says President and CEO, Dr. Mohan Cooray. “As a result, we’ve seen an upsurge in cannabis use among patients managing symptoms such as pain, anxiety, difficulty sleeping, and stress – especially from symptoms related to COVID-19 isolation.  Cannabis is a natural plant medicine that can be used safely to manage mental health issues without the dependency effects we see from alcohol, opioids or narcotics.  During this unprecedented time and without access to storefront retailers, we want to help Canadians receive the products they need,” he says.

Additionally, with limited access to doctors or pharmacists during self-isolation, Cannalogue’s medical staff can assess and provide dosage recommendations over the phone.  “Cannalogue is an essential national medical service that Health Canada has confirmed will be fully available to patients during the pandemic. No matter how long we face the challenges of COVID-19, Cannalogue will be here to help,” says Dr. Cooray.

Ohio Board Of Pharmacy Publishes Updated MMJ Patient & Caregiver Numbers For February 2020

OHIO: The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for February 2020. These numbers include:

  • 102,200 Recommendations
  • 88,306 Registered patients
    • 6,545 Patients with Veteran Status
    • 6,018 Patients with Indigent Status
    • 506 Patients with a Terminal Diagnosis
  • 64,932 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 9,793 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.

Ohio Medical Marijuana Control Program Mandatory Product Recall – 3/13/2020

OHIO: The Ohio Medical Marijuana Control Program (MMCP) is issuing a mandatory product recall on plant material cultivated by Pure Ohio Wellness. This recall is being initiated by the MMCP because product that did not receive the full battery of required testing was sold at dispensaries. The product was not tested for heavy metals, water activity, microbials, mycotoxins, or foreign matter. The MMCP has initiated an investigation into the noncompliance and identified product samples to be tested. These results will be communicated publicly.

AFFECTED PRODUCT:

Product Name: Papaya Punch, Hiker’s Blend, and Tahoe Jack

Purchase Dates: May 10, 2019 – Present

Cultivator Name: Pure Ohio Wellness

Product ID:
• M00000022503: Tier 1 Vap-Hybrid-16.4-.04-Papaya Punch
• M00000022504: Tier 1 Vap-Hybrid-16.9-.07-Hikers Blend
• M00000022506: Tier 1 Vap-Hybrid-18.6-.03-Tahoe Jack
• M00000028027: Tier 1 Vap-Hybrid-14.21-0.05
• M00000032648: Tier 1 Vap-Hybrid-14.48-0.03
• M00000036302: Tier 1 Vap-Sativa-15.50-0
• M00000036303: Tier 1 Vap-Sativa-18.50-0
• M00000036307: Tier 1 Vap-Sativa-14.75-0
• M00000039234: Tier 1 Vap-Sativa-18.50-0 (103) 28.3g
• M00000039235: Tier 1 Vap-Sativa-14.75-0 (104) 8.49g
• M00000039236: Tier 1 Vap-Sativa-14.75-0 (104) 28.3g
• M00000039239: Tier 1 Vap-Sativa-14.75-0 (107) 8.49g
• M00000039240: Tier 1 Vap-Sativa-14.75-0 (107) 28.3g
• M00000039241: Tier 1 Vap-Sativa-15.50-0 (108) 8.49g
• M00000039242: Tier 1 Vap-Sativa-15.50-0 (108) 28.3g

No reports of adverse reactions for this product have been reported to the MMCP at this time.

Patients who have purchased the recalled product should stop using it. All unused product should be returned to the dispensary where purchased. Returned products will not count toward a patient’s 90-day possession limit. For more information on returns, please contact the dispensary where the product was purchased.

Anyone who thinks that they may be experiencing serious or life-threatening issues should seek immediate medical attention. Patients are reminded that any adverse reactions should be reported to the MMCP toll-free helpline (1-833-464-6627).

Ohio: OMMCP Issues Update On 11.15.19 Medical Marijuana Recall

OHIO: On November 17, 2019, the Ohio Medical Marijuana Control Program (MMCP) issued an updated mandatory product recall for three products (Pineapple Express, Blue Boi Z7, and Afghani #1). The original recall was issued on November 15, 2019.

The Ohio Department of Commerce mandated that samples of the recalled products be submitted for additional laboratory testing, and subsequently found that all products met the required testing standards for patient use.

The MMCP has completed its review of the One Orijin product recall; completing an executive summary which provides an analysis of the circumstances of the recall. The executive summary can be found here.

The full updated recall notice can be found here.

Ohio Board Of Pharmacy Awards Third Dispensary Certificate Of Operation In Newark

State_of_Ohio_Board_of_pharmacy_logo2C

 

OHIO: The State of Ohio Board of Pharmacy today awarded a Dispensary Certificate of Operation to Herbology, located at 1150 N. 21st St., Newark.

The Board has now issued 50 Dispensary Certificates of Operation.

The interactive map of Dispensaries with Certificates of Operation will be updated within two business days.

Ohio Board Of Pharmacy Publishes Updated Patient & Caregiver Numbers For January 2020

State_of_Ohio_Board_of_pharmacy_logo2C

OHIO: The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for January 2020.

These numbers include:

  • 94,771 Recommendations
  • 84,023 Registered patients
    • 6,163 Patients with Veteran Status
    • 5,382 Patients with Indigent Status
    • 473 Patients with a Terminal Diagnosis
  • 60,260 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 9,153 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.

Ohio Board Of Pharmacy Awards Second Dispensary Certificate Of Operation In Newark

State_of_Ohio_Board_of_pharmacy_logo2C

OHIO: The State of Ohio Board of Pharmacy today awarded a Dispensary Certificate of Operation to Ohio Grown Therapies, located at 1246 N. 21st St., Newark.

The Board has now issued 48 Dispensary Certificates of Operation.

The interactive map of Dispensaries with Certificates of Operation will be updated within two business days.

Beneficial Medical Cannabis Goes Mainstream With Online Seed Sales

Cannabis is widely considered a medical plant because of the many significant health benefits it brings. It has long been used for medicinal purposes worldwide, and has become a very popular trend in the United States, which has resulted in its legalization in more than 30 states.

Internationally, more and more countries have legalized cannabis consumption due to its therapeutic and medical use. In fact, there has been a lot of research that has demonstrated the benefits that can be obtained by consuming it. One of its main benefits is that it helps eliminate pain, especially chronic pain. Also, smoking cannabis can lead to the complete elimination of the need for more harmful drugs.

Likewise, its use is effective in: possible treatment of glaucoma, since it helps relieve intra-ocular pressure, helping to control epileptic seizures in children and young people, minimizing the development of breast cancer, it has beneficial effects on neurodegenerative diseases, the treatment of post-traumatic stress and schizophrenia, among others.

Cannabis is a plant that offers many benefits, but it also has a potential for risk and negative effects. Like all medications, safety depends on the way it is used. It should be noted that some users report that cannabis use impacts concentration and memory. However, based on studies, it is known that these negative effects are not permanent and disappear after you stop using it.

Given the potential of the benefits that can be obtained with its use, it is no wonder that cannabis use is widespread today. In addition to the thousands of dispensaries that have sprouted across the US, many patients are also growing their own. It is easy to buy seeds online, a way to quickly and safely acquire the best cannabis and with the best degree through discreet delivery methods.

Currently, the purchase of medical cannabis is legal in 33 states, and its online purchase has become popular in several of these states. First Step: Learn about the laws that govern your country and region to verify that it is legal to order, before you to make your purchase from the comfort of your home.

Ohio Board Of Pharmacy Awards Dispensary Certificate Of Operation In Lakewood

State_of_Ohio_Board_of_pharmacy_logo2C

OHIO: The State of Ohio Board of Pharmacy today awarded a Dispensary Certificate of Operation to Rise, located at 11818 Madison Ave., Lakewood.

The Board has now issued 46 Dispensary Certificates of Operation.

The interactive map of Dispensaries with Certificates of Operation will be updated within two business days.